View More Recent Stories

Dec 8, 2020 08:30AM Monopar Announces Initiation of its Phase 2b/3 (VOICE) Trial to Evaluate Validive® for the Prevention of Chemoradiotherapy-Induced Severe Oral Mucositis (SOM) in Oropharyngeal Cancer (OPC)
Nov 12, 2020 09:15AM Monopar Therapeutics Reports Third Quarter 2020 Financial Results and Business Update
Nov 12, 2020 09:15AM Monopar Therapeutics Reports Third Quarter 2020 Financial Results and Business Update
Nov 9, 2020 08:34AM Monopar Therapeutics (MNPR) Announces New Patents for Validive
Nov 9, 2020 08:30AM Monopar Announces Issuance of New Patents Broadening Protections For Phase 2b/3 Clinical-Stage Lead Product Candidate Validive®
Nov 9, 2020 08:30AM Monopar Announces Issuance of New Patents Broadening Protections For Phase 2b/3 Clinical-Stage Lead Product Candidate Validive®
View More Recent Stories